| The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation S Lovera, L Sutto, R Boubeva, L Scapozza, N Dölker, FL Gervasio Journal of the American Chemical Society 134 (5), 2496-2499, 2012 | 124 | 2012 |
| Conformational selection and induced fit mechanisms in the binding of an anticancer drug to the c-Src kinase MA Morando, G Saladino, N D’Amelio, E Pucheta-Martinez, S Lovera, ... Scientific reports 6 (1), 24439, 2016 | 91 | 2016 |
| Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics S Lovera, M Morando, E Pucheta-Martinez, JL Martinez-Torrecuadrada, ... PLoS computational biology 11 (11), e1004578, 2015 | 75 | 2015 |
| Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist B Sun, D Feng, MLH Chu, I Fish, S Lovera, ZA Sands, S Kelm, A Valade, ... Nature communications 12 (1), 3305, 2021 | 67 | 2021 |
| Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance I Galdadas, S Lovera, G Pérez-Hernández, MD Barnes, J Healy, ... Scientific Reports 8 (1), 12916, 2018 | 52 | 2018 |
| PlayMolecule CrypticScout: predicting protein cryptic sites using mixed-solvent molecular simulations G Martinez-Rosell, S Lovera, ZA Sands, G De Fabritiis Journal of Chemical Information and Modeling 60 (4), 2314-2324, 2020 | 38 | 2020 |
| Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots S Lovera, A Cuzzolin, S Kelm, G De Fabritiis, ZA Sands Scientific Reports 9 (1), 14199, 2019 | 37 | 2019 |
| NaViA: a program for the visual analysis of complex mass spectra D Quetschlich, TK Esser, TD Newport, F Fiorentino, D Shutin, S Chen, ... Bioinformatics 37 (24), 4876-4878, 2021 | 18 | 2021 |
| The Aminotriazole Antagonist Cmpd‐1 Stabilises a Novel Inactive State of the Adenosine 2A Receptor EJB Landin, S Lovera, G de Fabritiis, S Kelm, J Mercier, D MacMillan, ... Angewandte Chemie, 2019 | 9 | 2019 |
| Deconstructing allostery by computational assessment of the binding determinants of allosteric PTP1B modulators A Hardie, BP Cossins, S Lovera, J Michel Communications Chemistry 6 (1), 125, 2023 | 7 | 2023 |
| Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D2 Receptor HD Lim, D Bartuzi, AC Keen, C Rauffenbart, J Glenn, SJ Charlton, ... ACS Chemical Neuroscience 16 (12), 2295-2311, 2025 | 2 | 2025 |
| Above-Filter Digestion Proteomics reveals drug targets and localizes ligand binding site B Sokolova, H Gharibi, M Jafari, H Lyu, S Lovera, M Gaetani, AA Saei, ... bioRxiv, 2025.03. 11.642584, 2025 | 1 | 2025 |
| Elucidation of the mechanism of partial activation of EPAC1 allosteric modulators by Markov state modelling A Hardie, FG Powell, S Lovera, SJ Yarwood, G Barker, J Michel Chemical Science 16 (32), 14771-14781, 2025 | 1 | 2025 |
| N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis C PEGURIER, S Lovera, CE MUELLER, J HOCKEMEYER, M Rashed, ... US Patent 12,358,875, 2025 | | 2025 |
| Exploring the role of conformational dynamics in the regulation of tyrosine kinases. S Lovera UCL (University College London), 2016 | | 2016 |
Francesco Luigi GervasioProfessor of Pharmaceutical Sciences at University of Geneva & Professor of Chemistry UCLVerified email at unige.ch
